Update carbon_salbutamol.json

added NICE guidance, changed MO opportunities

openprescribing/measures/definitions/carbon_salbutamol.json

@@ -6,11 +6,19 @@
   "denominator_short": "Salbutamol inhalers",
   "y_label": "kgCO2e per salbutamol inhaler",
   "why_it_matters": [
+    "<p>The updated <a href='https://www.nice.org.uk/guidance/ng245/chapter/Recommendations#principles-of-pharmacological-treatment' target='_Blank'>BTS/NICE/SIGN guidance on asthma management</a> recommends basing inhaler choice on:",
+    "<i>",
+    "<ul>",
+    "<li>an assessment of correct technique</li>",
+    "<li>the preference of the person receiving the treatment</li>",
+    "<li>he lowest environmental impact among suitable devices</li>",
+    "<li>the presence of an integral dose counter.</li>",
+    "</ul></i></p>",
     "The NHS has <a href='https://www.england.nhs.uk/greenernhs/a-net-zero-nhs/' target='_Blank'> ",
     "committed to reducing its carbon footprint by 80% by 2028 to 2032</a>, including a shift to lower carbon inhalers.</p>",
     "<p>Salbutamol metered dose inhalers (MDIs) are the single biggest source of carbon emissions from NHS medicines prescribing.</p>",
     "<p>The <a href='https://www.england.nhs.uk/long-read/national-medicines-optimisation-opportunities-2023-24/#11-improving-respiratory-outcomes-while-reducing-the-carbon-emissions-from-inhalers' target='_Blank'>",
-    "NHS England National Medicines Optimisation Opportunities for 2023/24</a> identify reducing carbon emissions from inhalers as an area for improvement.</p>",
+    "NHS England National Medicines Optimisation Opportunities for 2024/25</a> identify reducing carbon emissions from inhalers as an area for improvement.</p>",
     "<p>Data on carbon emissions per salbutamol inhaler can be viewed in the ",
     "<a href='https://docs.google.com/spreadsheets/d/1eyk2iqNM_4sobDzevZWWcRR00O2tmJO5HwdFZLjhfa4' target='_Blank'>",
     "table here</a>.</p>"